NASDAQ:AMAG
Delisted
AMAG Pharmaceuticals Stock News
$13.75
+0 (+0%)
At Close: May 27, 2022
WALTHAM, Mass., Dec. 14, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. has submitted its response to the FDA's Notice of Opportunity for a Hearing (“NOOH”) regarding the Agency's proposal to
Lifshitz Law Firm, P.C. Announces Investigation of AMAG Pharmaceuticals, Inc., Contango Oil & Gas Company, Eaton Vance Corp., MobileIron, Inc., Seacoast Commerce Banc Holdings, Perceptron, Inc., Standard AVB Financial Corp., Virginia National Bankshares Corporation and Virtusa Corporation
07:31pm, Wednesday, 04'th Nov 2020
NEW YORK, Nov. 4, 2020 /PRNewswire/ -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of
Charting a pulling-teeth breakout attempt: S&P 500, Nasdaq challenge record territory
04:41pm, Tuesday, 18'th Aug 2020
Technically speaking, the S&P 500 and Nasdaq Composite have registered nominal record highs this week, though a pulling-teeth breakout attempt remains...
AMAG Pharmaceuticals (AMAG) Moves to Buy: Rationale Behind the Upgrade
04:00pm, Wednesday, 12'th Aug 2020
AMAG Pharmaceuticals (AMAG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).
Charting the approach of record highs, S&P 500 rises amid market rotation
04:49pm, Tuesday, 11'th Aug 2020
Technically speaking, the U.S. benchmarks’ already-bullish backdrop has strengthened amid rotational August price action, writes Michael Ashbaugh.
AMAG Pharmaceuticals (NASDAQ:AMAG) Price Target Raised to $10.00 at SVB Leerink
01:52am, Tuesday, 11'th Aug 2020
AMAG Pharmaceuticals (NASDAQ:AMAG) had its price objective increased by SVB Leerink from $9.00 to $10.00 in a research note issued to investors on Friday morning, BenzingaRatingsTable reports. The fir
AMAG Pharmaceuticals' (AMAG) Q2 Loss Narrower Than Expected
02:45pm, Friday, 07'th Aug 2020
AMAG (AMAG) posts a narrower-than-expected loss and revenues miss estimates in the second quarter of 2020.
AMAG Pharmaceuticals (AMAG) Reports Q2 Loss, Lags Revenue Estimates
01:55pm, Thursday, 06'th Aug 2020
AMAG Pharmaceuticals (AMAG) delivered earnings and revenue surprises of 16.67% and -6.61%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
AMAG Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Corporate Update
11:00am, Thursday, 06'th Aug 2020
Financial guidance reissued to include EBITDA-positive projection for second-half 2020 Strategic shift and momentum build through recent business development activitiesBrian Piekos promoted to Chief
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO
12:00am, Thursday, 06'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 5)
ABIOMED, Inc. (NASDAQ: ABMD)
Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) (announced a U.S. government grant for a...
Charting a solid August start: S&P 500, Nasdaq stage latest summer breakouts
04:38pm, Tuesday, 04'th Aug 2020
Technically speaking, the U.S. benchmarks’ bigger-picture backdrop remains bullish amid a solid August start, writes Michael Ashbaugh.
Dupont Capital Management Corp Has $532,000 Stake in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG)
05:18am, Monday, 03'rd Aug 2020
Dupont Capital Management Corp decreased its holdings in shares of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) by 18.4% in the 2nd quarter, Holdings Channel reports. The institutional investor owned 69,5
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
AMAG Pharmaceuticals (AMAG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
04:33pm, Thursday, 30'th Jul 2020
AMAG Pharmaceuticals (AMAG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AMAG Pharmaceuticals to Host Second Quarter FY 2020 Financial Results Conference Call and Webcast on Thursday, August 6, 2020
12:00pm, Tuesday, 28'th Jul 2020
WALTHAM, Mass., July 28, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its second quarter 2020 financial results will be released on Thursday, August 6, 2020
